Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-743-9 | CAS number: 372-09-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- The animals were dosed between 1979-06-21 and 1979-07-26.
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study, no GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 980
- Report date:
- 1980
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- BASF Test (BASF internal method). In principle, the methods described by OECD TG 401 are followed.
- GLP compliance:
- no
- Remarks:
- pre-GLP study
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Cyanoacetic acid
- EC Number:
- 206-743-9
- EC Name:
- Cyanoacetic acid
- Cas Number:
- 372-09-8
- Molecular formula:
- C3H3NO2
- IUPAC Name:
- cyanoacetic acid
- Details on test material:
- - Name of test material (as cited in study report): Cyanessigsäure (cyanoacetic acid)
- Analytical purity: not given
No further data
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
male and female Sprague-Dawley rats
- Source: Hagemann
- Weight at study initiation: mean body weights: 210 - 280 g (males); 180 - 210 g (females)
- Fasting period before study: 15 - 20 h prior to dosing
- Diet (ad libitum): Herilan MRH Haltungsdiät (H. Eggersmann KG)
- Water (ad libitum): tap water
ENVIRONMENTAL CONDITIONS: no data
IN-LIFE DATES: no data
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
distilled water
- Concentration in vehicle: 4.64, 6.81, 10.00, 14.70, 21.50 % (w/v)
DOSE VOLUME APPLIED: 10 ml/kg bw for all dose groups - Doses:
- 464, 681, 1000, 1470, 2150 mg/kg bw
- No. of animals per sex per dose:
- 5 males and 5 females per group
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: (a) mortality check: 1h, 1d, 2d, 7d, 14d after dosing; (b) weighing: 2-4d, 7d, 13d after dosing
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross pathology - Statistics:
- Probit Analysis according to Finney DJ (1971). Probit Analysis. Cambridge University Press, 3rd ed.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 010 mg/kg bw
- 95% CL:
- 831 - 1 228
- Remarks on result:
- other: slope factor: 1.45
- Mortality:
- Mortality after 14 days:
464 mg/kg bw: 0/10
681 mg/kg bw): 1/10
1000 mg/kg bw: 7/10
1470 mg/kg bw: 7/10
2150 mg/kg bw: 10/10
All deaths occurred within the first day after dosing. For more details, see below, table 1. - Clinical signs:
- other: 464 and 681 mg/kg bw: no clinical signs. 1000 mg/kg bw: dyspnea, wheezing, apathy, staggering, piloerection, poor general state. 1470 mg/kg bw: dyspnea, apathy, anomal position, staggering, tremor, exsiccosis, paresis, poor general state. 2150 mg
- Gross pathology:
- Pathology of the decedents revealed changes of the heart (acute dilatation at the right side, acute congestive hyperemia), liver (dark-gray coloration, reddish-brown marmoration), and stomach (whitish mucosa, hemorrhagic ulceration). No pathological abnormalities were found in survivors that had been sacrificed at the end of the observation period.
Any other information on results incl. tables
Table 1: mortality data
Dose level [mg/kg] |
464 |
681 |
1000 |
1470 |
2150 |
|
males |
||||||
No. of animals |
5 |
5 |
5 |
5 |
5 |
|
Dead animals after |
1 h 1 d 2 d 7 d 14 d |
0 0 0 0 0 |
0 0 0 0 0 |
0 3 3 3 3 |
0 3 3 3 3 |
1 5 5 5 5 |
females |
||||||
No. of animals |
5 |
5 |
5 |
5 |
5 |
|
Dead animals after |
1 h 1 d 2 d 7 d 14 d |
0 0 0 0 0 |
0 1 1 1 1 |
0 4 4 4 4 |
0 4 4 4 4 |
3 5 5 5 5 |
Table 2: body weight data
Dose level [mg/kg] |
464 |
681 |
1000 |
1470 |
2150 |
|
males |
||||||
Initial body weight [g] |
230 |
210 |
280 |
210 |
230 |
|
Body weight [g] after |
2-4 d 7 d 13 d |
253 285 312 |
230 267 303 |
277 271 272 |
183 224 265 |
All animals were dead by day 1. |
females |
||||||
Initial body weight [g] |
180 |
170 |
210 |
190 |
190 |
|
Body weight [g] after |
2-4 d 7 d 13 d |
190 201 195 |
186 193 206 |
210 233 235 |
184 211 233 |
All animals were dead by day 1. |
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Remarks:
- Migrated information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.